← FDA Drug Approvals (Drugs@FDA)

KESIMPTA

BLA · Biologics License Application · Sponsor: NOVARTIS · Approved 2009-10-26

Drug application

FDA Application #

BLA125326

Application type

Biologics License Application

Brand name

KESIMPTA

Generic name

OFATUMUMAB

Active ingredients

OFATUMUMAB

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2009-10-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown